subscribeSubscribe
Merck, J&J and Allergan Seek Changes on FDA Draft Guidance on Hormonal Contraceptive Labeling

Merck, J&J and Allergan Seek Changes on FDA Draft Guidance on Hormonal Contraceptive Labeling
RAPS
07 Mar 2018
Share Share
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report

Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Angus Liu FIERCE PHARMA
06 Jan 2018
Share Share
Sanofi introduces new Priftin packaging to treat latent tuberculosis

Sanofi introduces new Priftin packaging to treat latent tuberculosis
PR NEWS WIRE
03 Dec 2015
Share Share
AbbVie Demonstrate Commitment to Hep C Patients with New Data on VIEKIRA PAK™

AbbVie Demonstrate Commitment to Hep C Patients with New Data on VIEKIRA PAK™
PR NEWSWIRE
01 Oct 2015
Share Share
AbbVie`s VIEKIRAX Receives Approval in Japan for Chronic Hepatitis C

AbbVie`s VIEKIRAX Receives Approval in Japan for Chronic Hepatitis C
PR NEWS WIRE
28 Sep 2015
Share Share
NHS England stumps up £190m for hep C therapy

NHS England stumps up £190m for hep C therapy
Selina Mckee PHARMATIMES
12 Jun 2015
Share Share
Hep C landscape shifts again as BMS combo nabs breakthrough tag

Hep C landscape shifts again as BMS combo nabs breakthrough tag
Eric Palmer FIERCE PHARMA
20 May 2015
Share Share
Ranks of `super-spender` patients triple, pushing drug bills up $52B

Ranks of `super-spender` patients triple, pushing drug bills up $52B
 Tracy Staton FIERCE PHARMA
13 May 2015
Share Share
Gilead ready to take the cash from hep C superstars and buy something

Gilead ready to take the cash from hep C superstars and buy something
Eric Palmer FIERCE PHARMA
01 May 2015
Share Share
AbbVie says disappointing Viekira sales numbers are misleading

AbbVie says disappointing Viekira sales numbers are misleading
 Carly Helfand FIERCE PHARMA MARKETING
28 Apr 2015
Share Share